Title: Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
Authors: Applebaum, Katie M; Karagas, Margaret R; Hunter, David J; Catalano, Paul J; Byler, Steven H; Morris, Steve; Nelson, Heather H
Published In Environ Health Perspect, (2007 Aug)
Abstract: BACKGROUND: Arsenic exposure may alter the efficiency of DNA repair. UV damage is specifically repaired by nucleotide excision repair (NER), and common genetic variants in NER may increase risk for non-melanoma skin cancer (NMSC). OBJECTIVE: We tested whether polymorphisms in the NER genes XPA (A23G) and XPD (Asp312Asn and Lys751Gln) modify the association between arsenic and NMSC. METHODS: Incident cases of basal and squamous cell carcinoma (BCC and SCC, respectively) were identified through a network of dermatologists and pathology laboratories across New Hampshire. Population-based controls were frequency matched to cases on age and sex. Arsenic exposure was assessed in toenail clippings. The analysis included 880 cases of BCC, 666 cases of SCC, and 780 controls. RESULTS: There was an increased BCC risk associated with high arsenic exposure among those homozygous variant for XPA [odds ratio (OR) = 1.8; 95% confidence interval (CI), 0.9-3.7]. For XPD, having variation at both loci (312Asn and 751Gln) occurred less frequently among BCC and SCC cases compared with controls (OR = 0.8; 95% CI, 0.6-1.0) for both case groups. In the stratum of subjects who have variant for both XPD polymorphisms, there was a 2-fold increased risk of SCC associated with elevated arsenic (OR = 2.2; 95% CI, 1.0-5.0). The test for interaction between XPD and arsenic in SCC was of borderline significance (p < 0.07, 3 degrees of freedom). CONCLUSIONS: Our findings indicate a reduced NMSC risk in relation to XPD Asp312Asn and Lys751Gln variants. Further, these data support the hypothesis that NER polymorphisms may modify the association between NMSC and arsenic.
PubMed ID: 17687452
MeSH Terms: Adult; Aged; Arsenic/analysis; Arsenic/toxicity*; Carcinogens/analysis; Carcinogens/toxicity; Carcinoma, Basal Cell/epidemiology; Carcinoma, Basal Cell/genetics*; Carcinoma, Squamous Cell/epidemiology; Carcinoma, Squamous Cell/genetics*; Environmental Exposure/adverse effects; Environmental Exposure/analysis; Environmental Pollutants/analysis; Environmental Pollutants/toxicity; Female; Genotype; Humans; Male; Middle Aged; Nails/chemistry; New Hampshire/epidemiology; Polymorphism, Genetic; Skin Neoplasms/epidemiology; Skin Neoplasms/genetics*; Xeroderma Pigmentosum Group A Protein/genetics*; Xeroderma Pigmentosum Group D Protein/genetics*